Refreshing results…
The CCR6–CCL20 axis promotes regulatory T cell glycolysis and immunosuppression in tumors
UploadCorrecting the drug development paradigm for glioblastoma requires serial tissue sampling
UploadTumor inflammation-associated neurotoxicity
UploadCurrent Vaccine Trials in Glioblastoma: A Review
Download from doi.orgMissing publications? Search for publications with a matching author name.